Clozapine-Induced Aplastic Anemia in a Patient with Parkinson's Disease

Wolters EC Berendse HW . Management of psychosis in Parkinson's disease. Curr Opin Neurol 2001;14:499–504.

Van De Vijver DA Ross RA Jansen PA Porsius AJ De Boer A. Antipsychotics and Parkinson's disease: Association with disease and drug choice during the first 5 years of antiparkinsonian drug treatment. Eur J Clin Pharmacol 2002;58:15761.

Angst J Bente D Berner P Heimann H Helmchen H Hippius H. Das klinische Wirkungsbild von Clozapin (Untersuchungen mit dem AMP-System). Pharmacopsychiatrie 1971;13:201–11.

Alvir JMJ Liebermann JA Saffermann AZ Schwimmer JL Schaaf JA . Clozapine-induced agranulocytosis. N Engl J Med 1993;329:162–7.

Vial T Gallant C Choquet-Kastlevsky G Descotes J. Treatment of drug induced agranulocytosis with hematopoietic growth factors. A review of the clinical experience. Biodrugs 1999;11:185–200.